Clinical Trial: Venous Resection in Patients Undergoing Pancreatic Surgery

U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07621029) titled 'Venous Resection in Patients Undergoing Pancreatic Surgery' on May 27.

Brief Summary: Pancreatic surgery is the only treatment in the multimodality approach to pancreatic cancer sine qua non long-term survival cannot be achieved. Pancreatectomy with vein resection (PVR) of the portal vein and the superior mesenteric vein (PV/SMV) to address tumors with venous infiltration has become standard of care in pancreatic surgery for the past 20 years. Larger series and meta-analyses show that long-term survival beyond the 5-year threshold can be achieved with PVR, but with somewhat inferior survivor compared to standard pancreatic resections...